Session Type
Meeting
Search Results for Renal
Abstract Number: 121
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Diuretic therapy is the mainstay of treatment for heart failure exacerbations but its optimal dosing strategy remains unclear. In 2011, the DOSE trial exhibited a trend toward improvement in patients’ global symptom assessments when utilizing a high-dose diuretic strategy, which used nearly 80mg intravenous furosemide three times daily in the first 72 hours on […]
Abstract Number: 122
Hospital Medicine 2020, Virtual Competition
Background: Renal dysfunction is a complication in patients with decompensated cirrhosis. Due to the potential morbidity and mortality of these disorders in cirrhotic patients, it is important to ensure accurate clinical measurements of renal function. Standard creatinine-based estimated glomerular filtration rate (eGFR) equations have proven to be inaccurate in cirrhotic patients, as these patients have […]
Abstract Number: 131
Hospital Medicine 2020, Virtual Competition
Background: Acute kidney injury (AKI) is a common complication of renal cell carcinoma or its treatment. It is unclear whether AKI, compared to inpatients with similar clinical and hospital-level characteristics without AKI, is associated with worse clinical outcomes and higher costs. To address this void, our study aimed to evaluate how an AKI diagnosis affects […]
Abstract Number: 133
Hospital Medicine 2020, Virtual Competition
Background: Rhabdomyolysis is a condition of rapid muscle breakdown resulting in myalgia, enzyme elevations, electrolyte imbalance. Released heme pigment may lead to tubular obstruction, vasoconstriction, and tubular epithelial cell injury, causing acute kidney injury (AKI) as a severe complication. Especially with predisposing conditions such as volume depletion. Early and aggressive fluid resuscitation is an essential […]
Abstract Number: 142
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The treatment of acute decompensated heart failure (ADHF) and comorbid acute kidney injury (AKI) can be quite challenging. Many times the etiology of AKI in this setting is multifactorial and may involve cardiorenal syndrome (CRS). Arterial underfilling, sympathetic nervous system upregulation, and systemic venous congestion contribute to impaired glomerular filtration rate in ADHF patients. […]
Abstract Number: 146
SHM Converge 2021
Background: Infants ≤ 60 days of age with a urinary tract infection (UTI) are a challenging population. Without clear guidelines for management, there is variability in renal imaging and antibiotic use. Our study examined patterns of renal imaging and antibiotic use in infants ≤ 60 days of age with UTI at a tertiary care children’s […]
Abstract Number: 223
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Medical Emergency Teams (METs) are utilized in an inpatient setting to identify patients who exhibit signs of clinical deterioration. Patients, family, or staff activate the team by calling a Code MET when there is a change in clinical status. Patients with End-Stage Renal Disease (ESRD) fare worse than age-, gender-, and race-matched populations. We […]
Abstract Number: 273
SHM Converge 2023
Background: Troponin is a big molecule, with its fragments not readily cleared by impaired renal function or during dialysis [1]. Oftentimes diagnosing myocardial injury/infarction (MI) is challenging in patients with ESRD due to atypical clinical features coupled with indeterminate ECG changes [2], and elevation of troponin levels with lower PPV [3]. In this study, we […]
Abstract Number: 326
SHM Converge 2021
Case Presentation: A 66-year-old female with a history of stage IV non-small cell lung cancer (NSCLC) (90% PD-L1 +) on pembrolizumab (status post cycle 9) with metastasis to the left adrenal gland presented with a two-week history of malaise, nausea, and vomiting. Vital signs were stable and physical exam was euvolemic, with mild epigastric tenderness. […]
Abstract Number: 332
SHM Converge 2021
Case Presentation: A 61 years old man with a history of metastatic rectal carcinoma T3 N0 M1 underwent neoadjuvant & adjuvant chemotherapy with FOLFOX along with resection of rectal tumor. One year later he had recurrent liver & sacral metastases for which he was started on FOLFIRI and bevacizumab with completion of 1 cycle of […]